NewsMateria's Malta EU-GMP Approval Opens-Up European Medical Market To...

Materia’s Malta EU-GMP Approval Opens-Up European Medical Market To Firm

-

MEDICAL cannabis and CBD wellness company Materia has won EU-GMP certification for its Malta facility allowing it to begin processing and exporting cannabis flower across Europe – including the lucrative German market.

The European Union Good Manufacturing Practices (EU GMP) certification has been issued to the London-based supplier and distributor by the Malta Medicines Authority.

It has been hailed by Materia’s chief executive, Deepak Anand, as a “significant milestone.” As most European countries require the EU GMP certification for companies to import and export cannabis goods. 

Mr Anand said: “We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis processor to the industry, especially global partners seeking access to the European market.”

Deepak Anand, Chief Executive Officer at Materia.

The company founded in 2018 and with a production and distribution network covering Germany, the UK, Malta and Denmark, also intends to imminently apply for a licence amendment to process cannabis extracts, leveraging the comprehensive preparatory work already completed.

Nick Pateras, Materia’s managing director, Europe, said: “We are tremendously proud to join the small group of cannabis companies with an EU GMP certified facility.

“Our team in Malta has been relentless in pursuit of this goal and adapted exceptionally to the circumstances of the last year, demonstrating why we consider them amongst the industry’s best.

“Having successfully developed our envisioned European infrastructure, commercialization now becomes our focus.” 

It took over two years for Materia to develop and prepare its Malta facility for inspection to successfully gain the EU GMP certification.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities - not...

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

Always Pure Organics Makes £3m Continental Swoop For Leading B2C Hemp And CBD Player

FAST-GROWING UK cannabis wholesaler Always Pure Organics has acquired two Belgian companies - Distribution Legal Hemp and NexGen -...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark...

New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane

THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000...

How Britain’s Three Crown Dependencies Are Stealing A Cannabis March On the Mainland

FRUSTRATED by the UK Government’s stance the three UK Crown Dependencies of Jersey, Guernsey and the Isle of Man,...

Must read

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former...

You might also likeRELATED
Recommended to you